Novocure (NVCR) Misses Q4 EPS by 6c

Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.36), $0.06 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $128.43 million versus the consensus estimate of $129.27 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus